FOCUS Investment Banking Represents Michigan ENT and Allergy Specialists in its Partnership with Parallel ENT and Allergy
Washington, DC, (November 30, 2023) – FOCUS Investment Banking (“FOCUS”), ...
How to Manage Risks When Selling Your Physician Practice
Based on the large number of medical practices acquired over ...
What is the Value of my Medical Practice?
This article focuses on how medical practices are valued by ...
FOCUS Investment Banking Named #1 Lower Middle Market M&A Advisor In Q2 2023
Washington, DC, (July 27, 2023) – FOCUS Investment Banking (“FOCUS”) ...
ENT & Allergy Practices Attract Private Equity
Armed with anywhere between $2 trillion and $4 trillion of ...
East Coast Retina, PA Case Study
East Coast Retina, PA has been acquired by Retina Consultants ...
FOCUS Investment Banking Represents East Coast Retina, PA in its Sale to Retina Consultants of America
Washington, DC, (June 20, 2023) – FOCUS Investment Banking (“FOCUS”), ...
Private Equity Interest in Orthopedics Grows
Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. But that’s been changing over the past few years and is likely to continue to grow moving forward.
Private Equity’s Increasing Consolidation of Oncology Practices
On April 23 a group led by private equity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 billion. AmerisourceBergen, the big drug wholesaler, is buying a minority stake in the firm; OneOncology’s affiliated practices, physicians, and management team will also retain a minority interest.
M&A Ophthalmology Deals Continue Into 2023 with Small And Mid-Size Transactions
The first quarter of 2023 delivered ten reported ophthalmology practice acquisitions, which aligns with seasonal acquisition trends (Q1 of 2022 reported eleven deals).
